Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group.
Shiriki Kumanyika(Drexel University), Nancy R. Cook(Brigham and Women's Hospital), Lana Shepek(Johns Hopkins University), Vera I. Lasser(Johns Hopkins University), J A Cutler(Rush University Medical Center), Marie Cameron(Johns Hopkins University), A Brewer(Johns Hopkins University), Carolyn Sugars, P R Hebert(Harvard University), Lyn M. Steffen(University of Minnesota)
Cited by 103
Related Papers
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
|Choice Reviews Online|2008|5.4k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
|New England Journal of Medicine|1996|2.4k